/ /

LATEST

Allergan to acquire CoolSculpting’s maker ZeltiqAllergan has announced that it has agreed to acquire ZELTIQ Aesthetics for $2.475 billion, a deal expected to close in the second half of the year.
Nitric oxide drug candidate falters in studyNovan, maker of the experimental topical acne treatment SB204, has announced that its nitric oxide-releasing drug achieved statistical significance in only one of three endpoints in one of two phase 3 trials.
Combined therapy targets inflammationResearchers treated a small cohort with two anti-inflammatory drugs and saw a significant improvement in clinical manifestations of disease. Further data showed the approach safely maintained results.
HS treatment requires multipronged approach
HS treatment requires multipronged approachEvidence supports combined treatments to target the many factors tied to hidradenitis suppurativa. See one expert's recommendations.
Derms take on female rejuvenationSome dermatologists are proponents of performing female rejuvenation procedures while others believe they are not part of the dermatologist’s domain. Few studies about the safety and effectiveness of these procedures have been performed and subjected to peer review. Dermatologists should consider working in conjunction with an OB/GYN to make sure the patient has received a complete examination and clearance before rejuvenation procedures are performed.
Nasal reconstruction after skin cancer surgeryDermatologists should consider the features of the nasal defect when weighing options for repair. Consider the desires of the patient when assessing options for both repair and treatments to mitigate post-surgical scar formation. The dermatologist must determine the choice of which procedure will likely achieve the best aesthetic outcome overall.
Practice gaps in childhood acne treatmentCombination therapies are under used; the role of diet, while controversial, may be beneficial; and, cosmeceuticals may remedy mild-to-moderate acne. Read more on acne treatment guidelines.
Starting a career in dermatology: 5 questionsResidency isn't forever, and young dermatologists on the verge of starting their careers must make big decisions.
February Clinical Considerations for NPs, PasIn our February Clinical Considerations, we take a look at treatment options for a few common skin disorders.
Data breaches: Fast factsBe sure to follow these steps if you think you've been hacked.

Poll

View Results